1. Home
  2. DVA vs NDSN Comparison

DVA vs NDSN Comparison

Compare DVA & NDSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • NDSN
  • Stock Information
  • Founded
  • DVA 1994
  • NDSN 1935
  • Country
  • DVA United States
  • NDSN United States
  • Employees
  • DVA N/A
  • NDSN N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • NDSN Industrial Machinery/Components
  • Sector
  • DVA Health Care
  • NDSN Industrials
  • Exchange
  • DVA Nasdaq
  • NDSN Nasdaq
  • Market Cap
  • DVA 10.9B
  • NDSN 10.1B
  • IPO Year
  • DVA 1995
  • NDSN N/A
  • Fundamental
  • Price
  • DVA $136.95
  • NDSN $209.55
  • Analyst Decision
  • DVA Hold
  • NDSN Strong Buy
  • Analyst Count
  • DVA 4
  • NDSN 6
  • Target Price
  • DVA $157.00
  • NDSN $258.33
  • AVG Volume (30 Days)
  • DVA 736.8K
  • NDSN 461.3K
  • Earning Date
  • DVA 08-05-2025
  • NDSN 08-20-2025
  • Dividend Yield
  • DVA N/A
  • NDSN 1.48%
  • EPS Growth
  • DVA 14.90
  • NDSN N/A
  • EPS
  • DVA 10.11
  • NDSN 7.78
  • Revenue
  • DVA $12,968,524,000.00
  • NDSN $2,704,444,000.00
  • Revenue This Year
  • DVA $6.46
  • NDSN $5.77
  • Revenue Next Year
  • DVA $3.24
  • NDSN $4.99
  • P/E Ratio
  • DVA $13.41
  • NDSN $27.13
  • Revenue Growth
  • DVA 5.11
  • NDSN 1.98
  • 52 Week Low
  • DVA $131.76
  • NDSN $165.03
  • 52 Week High
  • DVA $179.60
  • NDSN $266.86
  • Technical
  • Relative Strength Index (RSI)
  • DVA 44.92
  • NDSN 50.60
  • Support Level
  • DVA $134.64
  • NDSN $214.02
  • Resistance Level
  • DVA $138.26
  • NDSN $219.56
  • Average True Range (ATR)
  • DVA 2.71
  • NDSN 4.34
  • MACD
  • DVA 0.14
  • NDSN -0.98
  • Stochastic Oscillator
  • DVA 54.56
  • NDSN 15.04

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About NDSN Nordson Corporation

Nordson manufactures equipment (including pumps, valves, dispensers, applicators, filters, and pelletizers) used for dispensing adhesives, coatings, sealants, and other materials. The firm serves a diverse range of end markets including packaging, medical, electronics, and industrial. Nordson's business is organized into three segments: industrial precision solutions, medical and fluid solutions, and advanced technology solutions. The company generated approximately $2.7 billion in revenue in its fiscal 2024.

Share on Social Networks: